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PreviewsThe covalent modification of protein 
hydroxyls by phosphoryl groups is 
ubiquitous in biology. This simple 
chemical reaction is so important that 
the human genome encodes 478 pro-
tein kinases, as defined by the pres-
ence of a conserved 350 residue cata-
lytic domain (Manning et al., 2002). 
Protein kinases have a common “on” 
switch, in which they are phosphory-
lated on one or two serine, threonine, 
or tyrosine residues of a key segment 
known as the activation loop. Activa-
tion loop phosphorylation stabilizes the 
assembly of an enzymatic site compe-
tent for the Mg2+-dependent transfer of 
the γ-phosphoryl group of ATP to the 
substrate protein. Like Tolstoy’s happy 
families, the active conformations 
of protein kinases closely resemble 
one another. A common inactivation 
mechanism is their dephosphoryla-
tion by protein phosphatases. Given 
the critical role of kinases at the top 
of signaling cascades and other criti-
cal cellular decision points, diverse 
mechanisms of autoregulation have 
evolved in addition to dephosphoryla-
tion. These mechanisms depend on 
the composition and order of various 
domains and posttranslational modifi-
cation sites in the linker segments that 
connect the domains. The regulatory 
domains respond to cellular ligands, 
mediate protein-protein interactions, 
and are responsible for the subcellu-
lar distribution of the kinases. Some 
kinases, such as protein kinase A 
(PKA) (Kim et al., 2005), have evolved 
such that these regulatory functions 
are provided by separate chains. 
Two recent structural studies in Cell, 
including one in this issue, reveal 
the autoinhibitory 
mechanisms for 
two more kinases, 
FAK and ZAP-70 
(Lietha et al., 2007; 
Deindl et al., 2007). 
Every kinase family 
may thus be autoinhibited in its own 
way. Just as the “unhappy family” 
experience has provided inspiration 
to dramatists for centuries, the diverse 
repertoire of kinase autoinhibition 
mechanisms provides nearly inex-
haustible material for the structural 
biologist in search of drama at the 
molecular scale. 
The prototypical protein tyrosine 
kinase Src contains a Src-homology 
2 (SH2) domain and a Src-homology 3 
(SH3) domain in its N-terminal regula-
tory portion. SH2 domains bind to tyro-
sine-phosphorylated protein motifs, 
whereas SH3 domains typically bind 
to proline-rich sequence motifs. The 
first structural explanation for the auto-
inhibitory role of regulatory moieties 
of protein tyrosine kinases came with 
the structures of Src and Hck kinases 
(Figure 1, left) (Sicheri et al., 1997; Xu et 
al., 1997). The two structures showed 
how interdomain interactions, stabi-
lized by binding of the SH2 domain to 
the phosphorylated C terminus, lock 
the molecule in a closed conformation. 
This C-terminal phosphorylation is 
thus inhibitory, in contrast to activation 
loop phosphorylation. In a remarkable 
economy of binding surfaces, the SH3 
domains of Src, Hck, and another pro-
tein tyrosine kinase, Abl (Nagar et al., 
2006), dock onto a polyproline type II 
helix formed by the SH2-kinase linker 
sequence. Abl possesses all of the 
regulatory elements of Src but lacks 
the regulatory C-terminal tail; never-
theless, it has since been shown that 
a compensatory mechanism exists for 
the maintenance of the autoinhibited 
state (Nagar et al., 2006). These struc-
tures have been influential in thinking 
about the allosteric regulation of many 
other multimodular proteins besides 
protein kinases.
The technical challenges to determin-
ing structures of full-length or almost 
full-length multimodular kinases are 
still considerable. Conformational plas-
ticity is required for regulation but is an 
enemy of crystallization. Furthermore, 
heterogeneity in the phosphorylation 
state of the kinase must be avoided. 
These and other barriers have limited 
the number of such structures, in spite 
of their importance. FAK and ZAP-
70 are essential nonreceptor tyrosine 
kinases in adherent cells and T cells, 
respectively. In responding to extra-
cellular signals transduced by recep-
tors localized in the cell membrane, 
FAK and ZAP-70 mediate the tyrosine 
phosphorylation of downstream effec-
tors, thereby promoting diverse signal-
ing events. In the case of FAK, these 
signals modulate cellular growth, sur-
vival, and migration, whereas in the 
case of ZAP-70, they regulate T cell 
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In this issue, Lietha and colleagues (2007) report the structure of focal adhesion kinase 
(FAK) and reveal how FAK maintains an autoinhibited state. Together with the structure of 
another tyrosine kinase, ZAP-70 (Deindl et al., 2007), this work highlights the diversity of 
mechanisms that nature has evolved within the kinase superfamily to regulate their activity 
through autoinhibition.
“All happy families are alike; each unhappy 
family is unhappy in its own way.”
  
—Leo Tolstoy, Anna KareninaCell 129, June 15, 2007 ©2007 Elsevier Inc. 1037
Figure 1. A Protein Tyrosine Kinase Family Drama
Depicted are autoinhibited assemblies of Src, ZAP-70, and FAK. The structures are aligned based 
on their kinase domains; important regulatory linker segments are shown in orange. Inhibition is 
mediated by docking of the regulatory domains to the “back” side of the kinase domain in Src and 
ZAP-70 but by occlusion of the catalytic cleft on the opposite side by the FERM domain in FAK.proliferation and the secretion of cyto-
kines. The two new structures of auto-
inhibited ZAP-70 and FAK represent a 
significant accomplishment in the field. 
ZAP-70 and FAK contain a tandem pair 
of SH2 domains and a FERM (band 4.1, 
ezrin, radixin, moesin) domain, respec-
tively, in their regulatory regions. The 
FERM domain is a trilobed structure 
that is known to bind to phosphory-
lated protein sequence motifs and, in 
some cases, to lipids. The new struc-
tures show how these domains regu-
late the activity of the kinase catalytic 
domains.
The tandem SH2 domains of ZAP-
70 are special because they bind to 
a cognate doubly phosphorylated 
sequence known as an ITAM (immu-
noreceptor tyrosine-based activation 
motif) peptide in the cytoplasmic tails 
of the TCR ζ and CD3 chains. The 
ZAP-70 structure highlights the role 
of interdomain linkers and regulatory 
interactions with the “back” side of the 
catalytic domain (Figure 1, middle), as 
in Src and Hck. The active conforma-
tion of the ITAM-bound SH2 domains 
(Hatada et al., 1995) requires the 
breakdown of the autoinhibitory inter-
actions seen in the new ZAP-70 inter-
actions, offering a rationale for kinase 
activation. Upon activation, two linker 
tyrosine residues are exposed for 
phosphorylation, which may prevent 1038 Cell 129, June 15, 2007 ©2007 Elsreversion to the inactive conformation 
even after ITAM disengagement.
FAK illustrates an entirely different 
mode of inhibition that not only involves 
distinct binding surfaces but achieves 
inhibition by blocking access to the 
active site. The F2 lobe of the FERM 
domain docks onto the kinase domain 
C lobe, covering the substrate-bind-
ing site (Figure 1, right). Lietha et al. 
(2007) convincingly demonstrate that 
activation of FAK involves a sequen-
tial displacement of the FERM domain 
from the C lobe of the kinase and con-
comitant tyrosine phosphorylation of 
the activation loop. Furthermore, in 
contrast to the Src family, it is appar-
ent that its autoinhibition does not 
involve displacement of the αC helix of 
the kinase N lobe. The binding site for 
one major class of known ligands, the 
cytoplasmic tails of β-integrins, is distal 
to the site of contact with the catalytic 
domain. This means that binding of β-
integrin tails does not offer an obvious 
mechanism for the displacement of the 
FERM domain from its autoinhibitory 
conformation. Thus, the mechanism by 
which the FERM domain is displaced, 
leading to the activation of FAK, is still 
an open question.
There is now a growing list of kinase 
families in which autoinhibition has 
been characterized structurally. In 
addition to the Src, Abl, ZAP-70, and evier Inc.FAK families of cytoplasmic protein 
tyrosine kinases, autoinhibition has 
also been structurally demonstrated in 
the AGC serine/threonine kinase family 
(for example, PKA), the receptor tyro-
sine kinase family, and the calcium/
calmodulin-dependent protein kinase 
(CaMK) family. All three kinase fami-
lies mediate inhibition in unique ways, 
from a pseudosubstrate sequence in 
the case of PKA (Kim et al., 2005) to a 
juxtamembrane segment in the recep-
tor tyrosine kinases that occupies the 
catalytic cleft (Wybenga-Groot et al., 
2001) to a C-terminal autoinhibitory 
helix-loop-helix segment in the case 
of CaMKI (Goldberg et al., 1996). How 
many unique mechanisms of kinase 
autoinhibition are there? A quick glance 
at the human protein kinase family tree 
should leave kinase family dramatists 
feeling reassured that they are unlikely 
to run out of material any time soon.
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